 - Mandatory availability of adequate human biological material HBM: at least one FFPE tissue sample or fresh bone marrow sample in the case of hematological malignancies, from either the primary tumor andor recurrent tumor andor metastasis, obtained from any adequate surgery or biopsy, as well as blood sample at baseline and follow up; 